PharmaBoardroom

MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high…

IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s…

Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing…

The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated…

The vice president of Laboratorios Beta discusses the factors of why his organization is on the way to consolidating its different business lines…

MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time…

Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of…

The executive coordinator of GACTEC maps the current level of science and technology in Argentina and outlines the country's ambitions in this area,…

The National Heart Institute’s CEO portrays IJN as a national referral center for cardiovascular disease and declares: “IJN is equipped with the…

Chile is aiming to achieve complete bioequivalence of generics by the end of 2014. Chile’s Public Health Institute is leading the bioequivalence…

Graham Skarnvad arrived to Spain as country manager of ALK’s Spanish affiliate at the end of 2009, right when the crisis was in full swing. Later on…

The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you…